AVP and diabetes mellitus: While AVP appeared to improve glucose tolerance in animal experiments, recent findings have revealed an independent association between plasma copeptin, which is a stable C-terminal portion of pre/pro-vasopressin peptide and is used for a surrogate marker for circulating AVP, and risk of diabetes.